Actavis acquires Allergan

Valeant Pharmaceuticals International, the Canadian-based company that bought Bausch & Lomb for $8.7 billion in the spring of 2013, has lost its long and bitter battle to take over Allergan. A global leader in generic and branded drugs based in Dublin, Ireland, Actavis, has won with a friendlier bid for ...

Keep reading this article by becoming a member


Enjoy unrestricted access to Eyewear Intelligence

To continue reading this article subscribe now

  • Unlimited access to our highly trusted industry insights and analysis
  • Benchmark yourself against the market and competitors
  • Find inspiration to drive your business forward
  • Stay up to date with new business models and startups

If you aren’t ready to subscribe now, you can REGISTER FOR FREE. Already an Eyewear Intelligence subscriber? Sign in here.